Section of General Internal Medicine, University of Chicago, Chicago, Illinois.
Department of Internal Medicine, University of Michigan, Ann Arbor, Michigan.
Endocr Pract. 2023 Oct;29(10):787-793. doi: 10.1016/j.eprac.2023.07.031. Epub 2023 Aug 6.
There is no universal approach to the management of subclinical hypothyroidism (SCH). This study was designed to determine the impact of patient characteristics on management decisions in SCH amongst physician faculty members and trainees.
An online survey was distributed to faculty members and medical trainees (ie, interns, residents, and fellows) at multiple academic medical centers. The survey included 9 clinical scenarios describing women with SCH with 5 management options sequenced from most "conservative" (no further treatment or monitoring) to most "aggressive" (treatment with levothyroxine).
Of the 194 survey respondents, 95 (49.0%) were faculty members and 99 (51.0%) were trainees. Faculty members were more likely to report being "confident" or "very confident" in making the diagnosis of SCH compared to trainees (95.8% vs 46.5%, P < .001). Faculty members were also more likely to consider patient preference for treatment (60.0% vs 32.3%, P < .001). Among all respondents, the clinical factors that resulted in the highest predicted probability of treatment were hypothyroid symptoms (predicted probability [PP] 68.8%, 95% CI [65.7%-71.9%]), thyroid stimulating hormone >10 mIU/L in a 31-year-old (PP 63.9%, 95% CI [60.3%-67.3%]), and the desire for fertility (PP 52.2%, 95% CI [48.6%-56.0%]). In general, faculty members favored more aggressive treatment across all clinical scenarios.
The presence of symptoms, thyroid stimulating hormone >10 mIU/L, and desire for fertility were most predictive of the decision to treat in SCH. In several clinical scenarios, both trainee and faculty decision-making demonstrated discordance with general SCH management principles.
亚临床甲状腺功能减退症(SCH)的管理方法尚无定论。本研究旨在确定患者特征对医师教师和学员在 SCH 管理决策中的影响。
我们向多家学术医疗中心的教师和医学学员(即实习医师、住院医师和研究员)分发了在线调查。该调查包括 9 个描述患有 SCH 的女性的临床情况,每个情况有 5 种管理选项,从最“保守”(无需进一步治疗或监测)到最“积极”(用左甲状腺素治疗)。
在 194 名调查参与者中,95 名(49.0%)为教师,99 名(51.0%)为学员。与学员相比,教师更有可能报告“有信心”或“非常有信心”做出 SCH 诊断(95.8% 对 46.5%,P<0.001)。教师也更有可能考虑患者对治疗的偏好(60.0% 对 32.3%,P<0.001)。在所有参与者中,导致治疗预测概率最高的临床因素是甲状腺功能减退症状(预测概率[PP]68.8%,95%CI[65.7%-71.9%])、31 岁时促甲状腺激素(TSH)>10 mIU/L(PP 63.9%,95%CI[60.3%-67.3%])和生育愿望(PP 52.2%,95%CI[48.6%-56.0%])。总的来说,教师在所有临床情况下都倾向于更积极的治疗。
存在症状、TSH>10 mIU/L 和生育愿望是 SCH 治疗决策的最主要预测因素。在一些临床情况下,学员和教师的决策都与 SCH 的一般管理原则不一致。